scholarly journals The Use of DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Retrospective Cohort Study and Systematic Review of the Literature

2021 ◽  
Vol 233 (5) ◽  
pp. e12-e13
Author(s):  
Austin R. Swisher ◽  
Mark J. Landau ◽  
Nikita Kadakia ◽  
Stephanie W. Holzmer ◽  
Hahns Y. Kim
2018 ◽  
Vol 39 (3) ◽  
pp. 279-288 ◽  
Author(s):  
Elizabeth S Craig ◽  
Mark W Clemens ◽  
John C Koshy ◽  
James Wren ◽  
Zhang Hong ◽  
...  

2018 ◽  
Vol 1 (1) ◽  
pp. 142-148
Author(s):  
Robert Phan ◽  
Frank Lin ◽  
Dean White

Since its first reported use for the treatment of burns victims, acellular dermal matrix (ADM) use has expanded to surgeries including repairing thoracic and abdominal wall defects, and breast reconstruction. FlexHD® is a brand of ADM prepared from human cadaveric dermis that has been processed to remove antigenic components and is used to reinforce the subpectoral pocket created during submuscular breast implant surgery. Recent documentation of a phenomenon termed ‘red breast syndrome’ (RBS) has emerged in the medical literature, with little known about its aetiology and treatment. This paper presents a case of blistering cutaneous erythema from FlexHD® ADM.


Sign in / Sign up

Export Citation Format

Share Document